Role Of SLT In Glaucoma Management

This is a past event. Registration is closed. View other Asia Pacific Glaucoma Society – APGS events.

Save the date

Save the dateDecember 2, 202316:00 - 17:00 GMT+8

Organizer

Organizer: Asia Pacific Glaucoma Society – APGS

Contact Person: APGS Secretariat

Email: info@apglaucomasociety.org

Event Details

This APGS Webinar will cover:

Dropless/Less drop, New Trend In Glaucoma Management
SLT - Benefits & Rationale in Glaucoma Management
LiGHT Trial: What Have We Learnt and How Does It Apply

The APGS December Webinar will feature Assoc. Prof. Norman Aquino, Assoc. Prof. Manchima Makornwattana, Dr. Ganesh Raman and Dr. David Woo.

The session will happen on Saturday, 2 December 2023, 4:00 pm GMT+8, Singapore time.

Not sure when the webinar takes place in your location? Click here to convert the Webinar time to your local time.

Agenda

16:00 - 16:05
Introduction
Introduction
Norman M. Aquino
Associate Professor and Chief of Glaucoma Division at University of the Philippines-Philippine General Hospital
16:05 - 16:20
Dropless/Less Drop, New Trend In Glaucoma Management
Dropless/Less Drop, New Trend In Glaucoma Management
Manchima Makornwattana
Associate Professor, Department of Ophthalmology at Thammasat University Faculty of Medicine
Glaucoma is a long-life treatment. Eyedrops always the first-line of choice for glaucoma treatment because of their availability, easy to understand the concept of treatments, safer and more convenient. Unfortunately, there are many pain points using eyedrop such as patient compliance, complications both systemic and ocular.

The clinical outcomes of the LiGHT study have led to a paradigm shift in glaucoma care. Selective Laser Trabeculoplasty (SLT) is recommended as a first-line trea...
Glaucoma is a long-life treatment. Eyedrops always the first-line of choice for glaucoma treatment because of their availability, easy to understand the concept of treatments, safer and more convenient. Unfortunately, there are many pain points using eyedrop such as patient compliance, complications both systemic and ocular.

The clinical outcomes of the LiGHT study have led to a paradigm shift in glaucoma care. Selective Laser Trabeculoplasty (SLT) is recommended as a first-line treatment on POAG. Drop Less or Less Drop treatment that still preserve vision and improve quality-of life and vision seems to be more concerned in glaucoma care.
view more
16:20 - 16:35
SLT - Benefits & Rationale in Glaucoma Management
SLT - Benefits & Rationale in Glaucoma Management
Ganesh Raman
Chief of Glaucoma Services at Aravind Eye Hospital
Sharing by Dr. Ganesh Raman
16:35 - 16:50
LiGHT Trial: What Have We Learnt and How Does It Apply
LiGHT Trial: What Have We Learnt and How Does It Apply
David Woo
Assistant Medical Director of International Specialist Eye Centre Kuala Lumpur
Sharing by Dr. David Woo
16:50 - 17:00
Discussion and Q&A
Discussion and Q&A
All viewers can submit questions in the chat box, which will be reviewed. Only selected questions will be discussed.

Speakers

Norman M. Aquino

Associate Professor and Chief of Glaucoma Division at University of the Philippines-Philippine General Hospital

Manchima Makornwattana

Associate Professor, Department of Ophthalmology at Thammasat University Faculty of Medicine

Manchima Makornwattana

Associate Professor, Department of Ophthalmology at Thammasat University Faculty of Medicine

Associate Professor Manchima Makornwattana currently serves as the Director of Ophthalmology department, Faculty of Medicine at Thammasat University Hospital. She has been appointed Vice President of International Affairs at the Royal College of Ophthalmologist of Thailand (RCOPT), Secretary of the Subcommittee for Academic Affairs, and member of the Executive Committee for 12 consecutive years. She is currently the Co-Chief of International Affairs at the Thai Glaucoma Society and is a member of APAO Women In Ophthalmology’s (WIO) Standing Committee.

Dr. Makornwattana is a distinguished glaucoma and cataract specialist whose current major research interests includes angle closure glaucoma, factors related to intraocular pressure, surgical techniques, advanced technology in glaucoma diagnosis and surgery, premium and advanced technology of intraocular lens and cataract surgery. She co-developed an application for glaucoma patients to increase patient-compliance and knowledge about their disease for further glaucoma-prevention, which received a medal from the 47th International Exhibition of Inventions Geneva.

Dr. Makornwattana has written many chapters and articles on glaucoma, ocular surface, advanced technology intraocular lens, and cataract in other textbooks, and has published a book about glaucoma with the purpose of helping to promote public awareness and to prevent glaucoma blindness.

Ganesh Raman

Chief of Glaucoma Services at Aravind Eye Hospital

David Woo

Assistant Medical Director of International Specialist Eye Centre Kuala Lumpur

David Woo

Assistant Medical Director of International Specialist Eye Centre Kuala Lumpur

Dr. David Woo is a Glaucoma Specialist and Assistant Medical Director at International Specialist Eye Centre (ISEC) Kuala Lumpur, Malaysia. He is also the Southeast Asian Lead Resource Coordinator for AIER Eye Hospital Group, China.

Dr. Woo has a particular interest in the management of complex secondary glaucoma utilising a variety of Glaucoma Drainage Devices. He also retains a longstanding interest in Microinvasive Glaucoma Surgery, having first used MIGS devices in 2015 and subsequently becoming the first surgeon to set up a MIGS service in Northeast England in 2017.

Dr. Woo has a keen interest in medical education, and is a both a trainer and examiner for the UK Royal College of Ophthalmologists FRCOphth examinations. He is also a reviewer for several peer-reviewed Ophthalmology journals.

Sponsors and Partners

An Asia-Pacific Glaucoma Society Webinar Sponsored By Carl Zeiss

Introduction

Introduction

Dropless/Less Drop, New Trend In Glaucoma Management

Dropless/Less Drop, New Trend In Glaucoma Management

SLT - Benefits & Rationale in Glaucoma Management

SLT - Benefits & Rationale in Glaucoma Management

LiGHT Trial: What Have We Learnt and How Does It Apply

LiGHT Trial: What Have We Learnt and How Does It Apply

Discussion and Q&A

Discussion and Q&A

Norman M. Aquino

Associate Professor and Chief of Glaucoma Division at University of the Philippines-Philippine General Hospital

Manchima Makornwattana

Associate Professor, Department of Ophthalmology at Thammasat University Faculty of Medicine

Ganesh Raman

Chief of Glaucoma Services at Aravind Eye Hospital

David Woo

Assistant Medical Director of International Specialist Eye Centre Kuala Lumpur

Organizer

Sponsor